Which ICD‑10 code should I use to justify ordering a thyroid‑stimulating hormone (TSH) test for a patient who reports food or something feeling stuck (dysphagia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for TSH Testing in Dysphagia

Use ICD-10 code R13.10 (dysphagia, unspecified) as the primary diagnosis to justify ordering TSH, because thyroid dysfunction—both hypothyroidism and hyperthyroidism—can cause esophageal dysmotility and dysphagia that resolves with normalization of thyroid function. 1, 2, 3

Primary Diagnosis Code

  • R13.10 (dysphagia, unspecified) is the appropriate code when the patient reports food feeling stuck but the specific phase of swallowing has not yet been determined. 4

  • If clinical evaluation localizes the dysphagia, use more specific codes:

    • R13.12 (oropharyngeal dysphagia) if symptoms include difficulty initiating swallowing, coughing, choking, or nasal regurgitation 4
    • R13.13 (pharyngeal dysphagia) for isolated pharyngeal phase dysfunction 4
    • R13.19 (other dysphagia) for esophageal phase dysphagia 4

Clinical Justification for TSH Testing

Thyroid disease is a recognized but uncommon cause of dysphagia that must be excluded in the initial workup:

  • Hashimoto disease (hypothyroidism) causes esophageal motility disorders presenting as dysphagia or heartburn through hormonal effects on esophageal neuromuscular coordination. 1, 2

  • Severe hypothyroidism can cause dysphagia that resolves completely with levothyroxine treatment, even when extensive investigations reveal no obstructive cause. 2

  • Hyperthyroidism (Graves' disease, thyrotoxicosis) causes myopathic dysphagia affecting both liquids and solids, with severe cases requiring G-tube placement until thyroid function normalizes. 5, 3, 6

  • Dysphagia from thyrotoxicosis typically resolves within 3 weeks of anti-thyroid treatment on average, though severe cases may require 8 weeks. 3

  • Patients with thyrotoxicosis and dysphagia face higher risk for aspiration pneumonia and thyroid storm, making early recognition critical. 3

Additional Supporting Diagnosis Codes

If clinical features suggest thyroid disease, add:

  • E03.9 (hypothyroidism, unspecified) if symptoms include fatigue, weight gain, cold intolerance, or constipation 2

  • E05.90 (thyrotoxicosis, unspecified) if symptoms include weight loss, palpitations, sweating, or tremor 5, 3

  • R63.4 (abnormal weight loss) – commonly accompanies both thyroid-related dysphagia and structural esophageal pathology 5, 3, 6

Critical Clinical Pitfall

Never assume dysphagia is thyroid-related without imaging or endoscopy first. Abnormalities of the mid or distal esophagus can cause referred dysphagia to the throat, and up to 68% of patients with pharyngeal complaints have esophageal pathology. 4, 7, 8 The American College of Radiology recommends biphasic barium esophagram as the preferred initial test for dysphagia, with 96% sensitivity for structural and functional disorders. 7

Diagnostic Algorithm

  1. Order TSH alongside—not instead of—appropriate dysphagia imaging (modified barium swallow for oropharyngeal symptoms, biphasic esophagram for esophageal symptoms). 4, 7

  2. If TSH is abnormal and imaging shows esophageal dysmotility without structural lesions, treat the thyroid disorder and reassess dysphagia in 3-8 weeks. 2, 3

  3. If TSH is normal, proceed with upper endoscopy with biopsies to exclude mucosal lesions, eosinophilic esophagitis, and malignancy. 7

  4. If both imaging and endoscopy are normal but dysphagia persists, obtain high-resolution esophageal manometry to classify primary motility disorders. 7

References

Research

The thyroid and the gut.

Journal of clinical gastroenterology, 2010

Research

Myopathic dysphagia caused by thyrotoxicosis: a case report and review of the literature.

Endocrinology, diabetes & metabolism case reports, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thyrotoxicosis complicated with dysphagia.

Internal medicine (Tokyo, Japan), 2009

Research

Dysphagia as a primary manifestation of hyperthyroidism.

Journal of clinical gastroenterology, 1984

Guideline

Evaluation of Dysphagia – Endoscopy versus Swallow Studies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Immediate Management of Esophageal Obstruction due to Foreign Body Impaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How to manage episodic dysphagia in a patient with hyperthyroidism?
What other diseases can present with both chronic constipation and hypothyroidism in a patient whose constipation began before starting amlodipine?
What is the best course of treatment for a patient with chronic diarrhea and nasal regurgitation, who has developed food sensitivities to eggs, beef, lamb, and turkey, and has switched to a diet of pork, chicken, and fish?
What are the implications of a low blood carbon dioxide (CO2) level of 21 in a patient with Hashimoto's hypothyroidism, bipolar I disorder, gastroesophageal reflux disease (GERD), moderate gambling disorder, and generalized anxiety disorder?
What is the best management approach for a 55-year-old female with intermittent left flank pain, gastrointestinal symptoms, hypothyroidism on L-thyroxin, hyperglycemia, hyperlipidemia, and hyperuricemia?
Does gabapentin cause syncope?
How should I optimize glycemic control in a 61-year-old man with type 2 diabetes, chronic heart failure, A1c 10.9%, currently taking metformin 500 mg once daily?
What other angiotensin‑converting enzyme inhibitors are available besides lisinopril and enalapril, and what are their usual starting doses and contraindications?
What are the guideline-directed initial assessment and management steps for a patient presenting with suspected acute coronary syndrome?
What is the appropriate management for conjunctivitis in a patient allergic to erythromycin?
A patient with lymph node tuberculosis who is in the continuation phase of isoniazid + rifampicin develops sterile migratory polyarthritis (Poncet’s disease); how should the arthritis be treated and should the anti‑tuberculosis regimen be changed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.